Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Cold Remedy RapidMelts Cherry
- Development stage
- Unknown
- Lead developer
- Matrixx Initiatives
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
RapidMelts Cherry (Zicam Cold Remedy RapidMelts Cherry) is an over-the-counter (OTC) homeopathic cold-shortening remedy developed by Matrixx Initiatives (a subsidiary of Church & Dwight). Formulated as a quick-dissolve oral tablet with a cherry flavor, its active ingredients are Zincum aceticum (zinc acetate) 2x and Zincum gluconicum (zinc gluconate) 1x. The therapeutic mechanism of action relies on the release of ionic zinc (Zn2+) in the oral and pharyngeal cavity. These zinc ions are hypothesized to bind to intercellular adhesion molecule-1 (ICAM-1) receptors on the nasal and oral epithelium, competitively inhibiting rhinovirus binding and entry, thereby reducing the duration and severity of common cold symptoms when administered at the first sign of illness.
- Brand names
- RapidMelts CherryUltra RapidMelts - CherryZicam Cold Remedy RapidMelts - CherryZicam Cold Remedy RapidMelts CherryZicam Ultra Cold Remedy RapidMelts CherryZicam Zinc Cold Remedy RapidMelts Cherry
- Other names
- zinc acetate + zinc gluconatezinc acetate and zinc gluconatezincum aceticum + zincum gluconicumzincum aceticum and zincum gluconicum
02
Targets
ICAM1 (Intercellular Adhesion Molecule 1)
Beyond the preview
Go deeper on Zicam Cold Remedy RapidMelts Cherry.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zicam Cold Remedy RapidMelts Cherry.